- Research Projects
- Synopsis of completed research projects
Synopsis of completed research projects
HTA-methods & steering instruments
Transparency: Research questions in non-interventional drug studies (NIS), Update
Project leaders: Claudia Wild
Project team: Ozren Sehic
Duration: 2021 (1 PM)
AIHTA - Projekt „Transparency“
HTA-methods & steering instruments
Transparency: Sponsoring from patient initiatives, Update
Project leaders: Claudia Wild
Project team: Ozren Sehic
Duration: April 2021 –May 2021
AIHTA - Project „Transparency“
Prevention and screening
Stool DNA testing for colorectal cancer (CRC) screening
Project leaders: Gregor Goetz
Project team: Gregor Goetz
Duration: April 2021 – July 2021
Language: English (with German summary)
Publication: Policy Brief No 011: https://eprints.aihta.at/1335
High tech medicine
Evaluation of individual medical procedures - MEL 2021
Project leaders: Melanie Walter
Project co-operation: AIHTA staff for individual reviews
Duration: November 2020 – March 2021
HTA-methods & steering instruments
Public & philanthropic financial contribution to the development of new drugs 2: EC-FP7 Health Projects
Project leaders: Claudia Wild
Project team: Louise Schmidt
Duration: July 2020 – January 2021
Language: English
Publikation: Journalartikel
Psychological & psychiatric interventions
Effectiveness of music therapy
Project leaders: Claudia Wild
Project team: Lucia Gassner, Julia Mayer-Ferbas
Laufzeit: Juni bis Oktober 2020
Sprache: Englisch mit deutscher Zusammenfassung
Publication: HTA Projektbericht No. 133: http://eprints.aihta.at/1280/
HTA-methods & steering instruments
Framework for reimbursement decisions of digital health technologies (mHealth) and its (retrospective) application on selected examples
Project leaders: Claudia Wild
Project team: Reinhard Jeindl, Claudia Wild
Duration: May 2020 – November 2020
Language: German (with English summary)
Publication: HTA Project report No. 134: https://eprints.aihta.at/1279
Oncology, Prevention and screening, Health economics
Lung cancer screening in risk groups Systematic review(s) of effectiveness and utility (part 1) Costs and budgetary consequences (part 2)
Project leaders: Claudia Wild (part 1), Ingrid Zechmeister-Koss (part 2)
Project team:
- Thomas Semlitsch (IAVEM) & EUnetHTA partners (IQWIG, potentially others) (part 1)
- Christan Böhler, Sarah Wolf (part 2)
Duration: May 2020 – November 2020
Language: English with German summary
Publications:
HTA Project report No. 132a: http://eprints.aihta.at/1282/ (part 1)
HTA Projektbericht Nro 132b: https://eprints.aihta.at/1283 (part 2)
High tech medicine, European collaboration
Comparative effectiveness of surgical techniques and devices for the treatment of benign prostatic hyperplasia – German Summary of the EUnetHTA OCTA27 Assessment
Project leaders: Judit Erdös
Project team: Judit Erdös
& EUnetHTA partners (RER, VASPVT, SNHTA, Azienda Zero)
Duration: May 2020 – January 2021
Language: English with German summary
Publication: DSD No. 129: https://eprints.aihta.at/1328/
Prevention and screening, Health economics
Molecular genetic diagnostics as a triage mechanism in cardiology using the example of familial hypercholesterolemia: Organisational and ethical implications (part 1) and economic effects (part 2)
Project team: Melanie Walter, Christoph Strohmaier
Project lead: Melanie Walter (part 1), Christoph Strohmaier (part 2)
Duration: May 2020 – October 2020
Language: English (with German summary)
Publication: HTA Project report No. 130: http://eprints.aihta.at/1281/
